Pfizer Inc. History

235 East 42nd Street
New York, New York 10017-5755

Telephone: (212) 573-2323
Fax: (212) 573-7851

Public Company
Incorporated: 1900 as Charles Pfizer & Company Inc.
Employees: 50,900
Sales: $27.3 billion (1999 pro forma)
Stock Exchanges: New York Boston Cincinnati Midwest Pacific Philadelphia London Paris Brussels Zurich Swiss
Ticker Symbol: PFE
NAIC: 325412 Pharmaceutical Preparation Manufacturing; 325411 Medicinal and Botanical Manufacturing; 325413 In-Vitro Diagnostic Substance Manufacturing; 325414 Biological Product (Except Diagnostic) Manufacturing; 325611 Soap and Other Detergent Manufacturing; 325620 Toilet Preparation Manufacturing; 541710 Research and Development in the Physical, Engineering, and Life Sciences

Company Perspectives:

Our Mission: We will achieve and sustain our place as the world's premier research-based health care company. Our continuing success as a business will benefit patients and our customers, our shareholders, our families, and the communities in which we operate around the world. Key Dates:

Key Dates:

Henry Nock founds the business that eventually becomes Wilkinson Sword.
Charles Pfizer and Charles Erhart found Charles Pfizer & Company.
Parke-Davis is founded in Detroit by Hervey C. Parke and George S. Davis.

1870s:Dr. Joseph Lawrence develops the original formula for Listerine.
Wilkinson Sword begins making straight razors.
Lawrence sells his formula to Jordan Wheat Lambert, who founds Lambert Pharmacal Company.
William R. Warner founds William R. Warner & Company.
Several major U.S. gum producers merge to form American Chicle.
Charles Pfizer & Company Inc. is incorporated in New Jersey.
Warner & Co. acquires Richard Hudnut Company, a cosmetics firm.
Colonel Jacob Schick invents the Magazine Repeating Razor, forerunner of the Schick Injector razor.
Pfizer goes public.
Pfizer begins mass production of penicillin, primarily for the war effort.
Pfizer launches Terramycin, an antibiotic; Warner & Co. is renamed Warner-Hudnut, Inc.
Warner-Hudnut merges with Lambert Pharmacal to form Warner-Lambert Company.
Warner-Lambert acquires American Chicle.
Charles Pfizer & Company is renamed Pfizer Inc.; Warner-Lambert acquires Schick and Parke, Davis.
Agouron Pharmaceuticals, Inc. is founded.
Pfizer launches Procardia XL.
Pfizer launches Novasc, Zoloft, and Zithromax.
Warner-Lambert acquires Wilkinson Sword.
Pfizer acquires the animal health unit of SmithKline Beecham.
Warner-Lambert launches Lipitor through a marketing alliance with Pfizer.
Pfizer divests its Medical Technology Group; Pfizer launches Viagra.
Pfizer begins comarketing Celebrex; Warner-Lambert acquires Agouron Pharmaceuticals.
Pfizer acquires Warner-Lambert.

Company History:

Further Reading:

  • Alger, Alexandra, 'Viagra Falls,' Forbes, February 7, 2000, pp. 130--32.
  • Barrett, Amy, 'The Formula at Pfizer: Don't Run with the Crowd,' Business Week, May 11, 1998, pp. 96--97.
  • Baum, Laurie, 'A Powerful Tonic for Warner-Lambert,' Business Week, November 30, 1987, pp. 144, 146.
  • Benway, Susan Duffy, 'Just What the Doctor Ordered: `Restructuring' Revives Warner Lambert,' Barron's, December 30, 1985, pp. 35+.
  • Bradford, Stacey L., 'Sweet Dreams: Gum and Mints May Help Warner-Lambert Become a Bigger Success in Drugs,' Financial World, October 21, 1996, pp. 44--45.
  • Byrne, Harlan S., 'Warner-Lambert: On the Mend,' Barron's, January 2, 1995, pp. 19--20.
  • Campanella, Frank W., 'Healthy Turnaround: Warner-Lambert Is Poised for an Earnings Recovery,' Barron's, February 1, 1982, pp. 35+.
  • Davenport, Caroline H., 'Glowing Prospects: New Products Will Keep Pfizer Growing at a Healthy Clip,' Barron's, December 22, 1980.
  • 'Did Warner-Lambert Make a `$468 Million Mistake'?,' Business Week, November 21, 1983, pp. 123+.
  • Gibson, W. David, 'R & D = Rx for Growth: That's Warner-Lambert's New Corporate Formula,' Barron's, February 20, 1984, pp. 13+.
  • Hayes, John R., 'Pill Selling 101,' Forbes, November 21, 1994, p. 64.
  • Hensley, Scott, 'Pfizer Appoints McKinnell to Top Posts,' Wall Street Journal, August 11, 2000, p. B10.
  • LaBell, Fran, 'Fat Extenders in Salad Dressings,' Food Processing, May 1992, p. 64.
  • Langreth, Robert, 'Behind Pfizer's Takeover Battle: An Urgent Need,' Wall Street Journal, February 8, 2000, p. B1.
  • ------, 'Pfizer's Warner-Lambert Purchase Contains Big Prize: Pipeline of Biotechnology Unit Agouron Is Stuffed with Potential Blockbusters,' Wall Street Journal, April 24, 2000, p. B4.
  • ------, 'Pfizer, Warner-Lambert Agree on Terms,' Wall Street Journal, February 7, 2000, p. A3.
  • Langreth, Robert, and Waldholz, Michael, 'Pfizer Pins Multibillion-Dollar Hopes on Impotence Pill,' Wall Street Journal, March 19, 1998, p. B1.
  • Loynd, Harry J., Parke-Davis: The Never-Ending Search for Better Medicines, New York: Newcomen Society in North America, 1957.
  • Lubove, Seth, 'Failure Focuses the Mind,' Forbes, November 8, 1993, pp. 76--78.
  • Mahar, Maggie, 'Legal Heartbreak?: Pfizer Faces Huge Liability If It Loses a Key Lawsuit,' Barron's, April 2, 1990, pp. 8+.
  • Mines, Samuel, Pfizer: An Informal History, New York: Pfizer, 1978.
  • O'Reilly, Brian, 'The Pills That Saved Warner-Lambert,' Fortune, October 13, 1997, pp. 94--95.
  • 'Pfizer: Counting on `Spare Parts' to Keep Up Its Momentum,' Business Week, January 9, 1984, pp. 109+.
  • 'Pfizer Joins with Other Drug Makers on Price Control,' Chemical Marketing Reporter, February 1, 1993, p. 7.
  • 'Pfizer Wins U.S. FDA Approval for Norvasc,' European Chemical News, August 17, 1992, p. 23.
  • Pratt, Edmund T., Jr., Pfizer: Bringing Science to Life, New York: Newcomen Society of the United States, 1985.
  • Rodengen, Jeffrey L., The Legend of Pfizer, Ft. Lauderdale, Fla.: Write Stuff Syndicate, 1999.
  • Roman, Monica, 'Pfizer Finally Sees Its Payoff,' Business Week, July 1, 1991, pp. 86+.
  • ------, 'Pfizer's Pipeline Is Full, But Will the Drugs Flow Fast Enough?,' Business Week, September 11, 1989, pp. 74+.
  • Rundle, Rhonda L., and Waldholz, Michael, 'Warner-Lambert Agrees to Buy Agouron,' Wall Street Journal, January 27, 1999, p. A3.
  • Schroeder, Michael, 'Heart Trouble at Pfizer,' Business Week, February 26, 1990, pp. 47+.
  • Starr, Cynthia, 'First-Ever Alzheimer's Drug Brings Some Hope to Millions,' Drug Topics, October 11, 1993, pp. 16--18.
  • Stipp, David, 'Why Pfizer Is So Hot,' Fortune, May 11, 1998, pp. 88--90, 92, 94.
  • Tanner, Ogden, Twenty-Five Years of Innovation: The Story of Pfizer Central Research, Lyme, Conn.: Greenwich Publishing, 1996.
  • 'Turning Warner-Lambert into a Marketing Conglomerate,' Business Week, March 5, 1979, p. 60.
  • 'Warner-Lambert: Reversing Direction to Correct Neglect,' Business Week, June 15, 1981, pp. 65+.
  • Weber, Joseph, 'Curing Warner-Lambert--Before It Gets Sick,' Business Week, December 9, 1991, pp. 91, 94.
  • Weber, Joseph, et al., 'The New Era of Lifestyle Drugs,' Business Week, May 11, 1998, pp. 92+.
  • Zipser, Andy, 'Beyond Shiley: A Vote for Pfizer,' Barron's, May 27, 1991, pp. 28+.

Source: International Directory of Company Histories, Vol. 38. St. James Press, 2001.